Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Antihistamines, Amantadine and Evolution of COVID-19

Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.

Who May Be Eligible (Plain English)

Who May Qualify: Patients having chronic treatment with antihistamines or amantadine - Who Should NOT Join This Trial: None \- Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Patients having chronic treatment with antihistamines or amantadine - Exclusion Criteria: None \-

Treatments Being Tested

DRUG

Antihistamine

Observation of the rate of COVID19 infection, the rate of hospitalization, the rate of survival and postcovid syndrome and thrombosis among patients previously treated with antihistamines

DRUG

Amantadine

Observation of the rate of COVID19 infection, the rate of hospitalization, the rate of survival and the rate of postcovid syndrome and thrombosis among patients previously treated with amantadine

Locations (2)

Hospital de Terrassa
Terrassa, Barcelona, Spain
Hospital of Terrassa
Terrassa, Barcelona, Spain